<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38324145</PMID><DateCompleted><Year>2024</Year><Month>07</Month><Day>30</Day></DateCompleted><DateRevised><Year>2024</Year><Month>08</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1439-0973</ISSN><JournalIssue CitedMedium="Internet"><Volume>52</Volume><Issue>4</Issue><PubDate><Year>2024</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Infection</Title><ISOAbbreviation>Infection</ISOAbbreviation></Journal><ArticleTitle>Endothelial dysfunction and cardiovascular risk in post-COVID-19 patients after 6- and 12-months SARS-CoV-2 infection.</ArticleTitle><Pagination><StartPage>1269</StartPage><EndPage>1285</EndPage><MedlinePgn>1269-1285</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s15010-024-02173-5</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">SARS-CoV-2 infection causes severe endothelial damage, an essential step for cardiovascular complications. Endothelial-colony forming cells (ECFCs) act as a biomarker of vascular damage but their role in SARS-CoV-2 remain unclear. The aim of this study was to assess whether the number of ECFCs and angiogenic biomarkers remained altered after 6 and 12-months post-infection and whether this imbalance correlated with the presence of long-COVID syndrome and other biological parameters measured.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Seventy-two patients were recruited at different time-points after overcoming COVID-19 and thirty-one healthy controls. All subjects were matched for age, gender, BMI, and comorbidities. ECFCs were obtained from peripheral blood and cultured with specific conditions.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The results confirm the presence of a long-term sequela in post-COVID-19 patients, with an abnormal increase in ECFC production compared to controls (82.8% vs. 48.4%, P&#x2009;&lt;&#x2009;0.01) that is maintained up to 6-months (87.0% vs. 48.4%, P&#x2009;&lt;&#x2009;0.01) and 12-months post-infection (85.0% vs. 48.4%, P&#x2009;&lt;&#x2009;0.01). Interestingly, post-COVID-19 patients showed a significant downregulation of angiogenesis-related proteins compared to controls indicating a clear endothelial injury. Troponin, NT-proBNP and ferritin levels, markers of cardiovascular risk and inflammation, remained elevated up to 12-months post-infection. Patients with lower numbers of ECFC exhibited higher levels of inflammatory markers, such as ferritin, suggesting that ECFCs may play a protective role. Additionally, long-COVID syndrome was associated with higher ferritin levels and with female gender.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">These findings highlight the presence of vascular sequela that last up to 6- and 12-months post-infection and point out the need for preventive measures and patient follow-up.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Poyatos</LastName><ForeName>Paula</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Pulmonary Medicine, Dr. Josep Trueta University Hospital de Girona, Santa Caterina Hospital de Salt and the Girona Biomedical Research Institute (IDIBGI), 17190, Girona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Sciences, Faculty of Medicine, University of Girona, Girona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luque</LastName><ForeName>Neus</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Pulmonary Medicine, Dr. Josep Trueta University Hospital de Girona, Santa Caterina Hospital de Salt and the Girona Biomedical Research Institute (IDIBGI), 17190, Girona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sabater</LastName><ForeName>Gladis</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Pulmonary Medicine, Dr. Josep Trueta University Hospital de Girona, Santa Caterina Hospital de Salt and the Girona Biomedical Research Institute (IDIBGI), 17190, Girona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Sciences, Faculty of Medicine, University of Girona, Girona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eizaguirre</LastName><ForeName>Saioa</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Pulmonary Medicine, Dr. Josep Trueta University Hospital de Girona, Santa Caterina Hospital de Salt and the Girona Biomedical Research Institute (IDIBGI), 17190, Girona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Sciences, Faculty of Medicine, University of Girona, Girona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bonnin</LastName><ForeName>Marc</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pulmonary Medicine, Dr. Josep Trueta University Hospital de Girona, Santa Caterina Hospital de Salt and the Girona Biomedical Research Institute (IDIBGI), 17190, Girona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Sciences, Faculty of Medicine, University of Girona, Girona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Orriols</LastName><ForeName>Ramon</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Pulmonary Medicine, Dr. Josep Trueta University Hospital de Girona, Santa Caterina Hospital de Salt and the Girona Biomedical Research Institute (IDIBGI), 17190, Girona, Spain. raorriols.girona.ics@gencat.cat.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Sciences, Faculty of Medicine, University of Girona, Girona, Spain. raorriols.girona.ics@gencat.cat.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Biomedical Research Networking Centre on Respiratory Diseases (CIBERES), Madrid, Spain. raorriols.girona.ics@gencat.cat.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tura-Ceide</LastName><ForeName>Olga</ForeName><Initials>O</Initials><Identifier Source="ORCID">0000-0003-4334-9790</Identifier><AffiliationInfo><Affiliation>Department of Pulmonary Medicine, Dr. Josep Trueta University Hospital de Girona, Santa Caterina Hospital de Salt and the Girona Biomedical Research Institute (IDIBGI), 17190, Girona, Spain. olgaturac@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Sciences, Faculty of Medicine, University of Girona, Girona, Spain. olgaturac@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Biomedical Research Networking Centre on Respiratory Diseases (CIBERES), Madrid, Spain. olgaturac@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pulmonary Medicine, Servei de Pneumologia, Hospital Cl&#xed;nic-Institut d'Investigacions Biom&#xe8;diques August Pi I Sunyer (IDIBAPS), University of Barcelona, Villarroel, 170, 08036, Barcelona, Spain. olgaturac@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>IFUdG2021</GrantID><Agency>Universitat de Girona</Agency><Country/></Grant><Grant><GrantID>CP17/00114</GrantID><Agency>Instituto de Salud Carlos III</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>02</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Infection</MedlineTA><NlmUniqueID>0365307</NlmUniqueID><ISSNLinking>0300-8126</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002318" MajorTopicYN="Y">Cardiovascular Diseases</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004730" MajorTopicYN="N">Endothelium, Vascular</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D066026" MajorTopicYN="N">Endothelial Progenitor Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Endothelial Biomarkers</Keyword><Keyword MajorTopicYN="N">Endothelial progenitor cell</Keyword><Keyword MajorTopicYN="N">Long-COVID</Keyword><Keyword MajorTopicYN="N">Post-COVID-19</Keyword><Keyword MajorTopicYN="N">Sequelae</Keyword><Keyword MajorTopicYN="N">Vascular injury</Keyword></KeywordList><CoiStatement>All the authors have read the journal's policy on conflicts of interest, declaring no conflicts of interest. All the authors have read the journal's authorship agreement.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>9</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>1</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>7</Month><Day>31</Day><Hour>0</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>2</Month><Day>7</Day><Hour>12</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>2</Month><Day>7</Day><Hour>11</Hour><Minute>10</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>2</Month><Day>7</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38324145</ArticleId><ArticleId IdType="pmc">PMC11289012</ArticleId><ArticleId IdType="doi">10.1007/s15010-024-02173-5</ArticleId><ArticleId IdType="pii">10.1007/s15010-024-02173-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Huertas A, Montani D, Savale L, Pichon J, Tu L, Parent F, et al. Endothelial cell dysfunction: a major player in SARS-CoV-2 infection (COVID-19)? Eur Respir J. 2020;56:2001634.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7301835</ArticleId><ArticleId IdType="pubmed">32554538</ArticleId></ArticleIdList></Reference><Reference><Citation>Sungnak W, Huang N, B&#xe9;cavin C, Berg M, Queen R, Litvinukova M, et al. SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes. Nat Med. 2020;26:681&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8637938</ArticleId><ArticleId IdType="pubmed">32327758</ArticleId></ArticleIdList></Reference><Reference><Citation>Ambrosino P, Calcaterra IL, Mosella M, Formisano R, D&#x2019;anna SE, Bachetti T, et al. Endothelial dysfunction in COVID&#x2010;19: a unifying mechanism and a potential therapeutic target. Biomedicines. 2022;10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9029464</ArticleId><ArticleId IdType="pubmed">35453563</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamming I, Timens W, Bulthuis MLC, Lely AT, Navis GJ, van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol. 2004;203:631&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7167720</ArticleId><ArticleId IdType="pubmed">15141377</ArticleId></ArticleIdList></Reference><Reference><Citation>Monteil V, Kwon H, Prado P, Hagelkr&#xfc;ys A, Wimmer RA, Stahl M, et al. Inhibition of SARS-CoV-2 infections in engineered human tissues using clinical-grade soluble human ACE2. Cell. 2020;181:905-913.e7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7181998</ArticleId><ArticleId IdType="pubmed">32333836</ArticleId></ArticleIdList></Reference><Reference><Citation>Maccio U, Zinkernagel AS, Shambat SM, Zeng X, Cathomas G, Ruschitzka F, et al. SARS-CoV-2 leads to a small vessel endotheliitis in the heart. EBioMedicine. 2021;63: 103182.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7808909</ArticleId><ArticleId IdType="pubmed">33422990</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Sw, Ilyas I, Weng Jp. Endothelial dysfunction in COVID-19: an overview of evidence, biomarkers, mechanisms and potential therapies. Acta Pharmacol Sin. 2023;44:695&#x2013;709.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9574180</ArticleId><ArticleId IdType="pubmed">36253560</ArticleId></ArticleIdList></Reference><Reference><Citation>Esper RJ, Nordaby RA, Vilari&#xf1;o JO, Paragano A, Cacharr&#xf3;n JL, Machado RA. Endothelial dysfunction: a comprehensive appraisal. Cardiovasc Diabetol. 2006;5:1&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1434727</ArticleId><ArticleId IdType="pubmed">16504104</ArticleId></ArticleIdList></Reference><Reference><Citation>Tombor LS, Dimmeler S. Why is endothelial resilience key to maintain cardiac health? Basic Res Cardiol. 2022;117:35.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9283358</ArticleId><ArticleId IdType="pubmed">35834003</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodr&#xed;guez C, Luque N, Blanco I, Sebastian L, Barber&#xe0; JA, Peinado VI, et al. Pulmonary endothelial dysfunction and thrombotic complications in COVID-19 patients. Am J Respir Cell Mol Biol. 2021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8008805</ArticleId><ArticleId IdType="pubmed">33180562</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonetti PO, Lerman LO, Lerman A. Endothelial dysfunction. Arterioscler Thromb Vasc Biol. 2003;23:168&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pubmed">12588755</ArticleId></ArticleIdList></Reference><Reference><Citation>Elyaspour Z, Zibaeenezhad MJ, Razmkhah M, Razeghian-Jahromi I. Is it all about endothelial dysfunction and thrombosis formation? The secret of COVID-19. Clin Appl Thromb. 2021;27:1&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8543709</ArticleId><ArticleId IdType="pubmed">34693754</ArticleId></ArticleIdList></Reference><Reference><Citation>Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel AS, et al. Endothelial cell infection and endotheliitis in COVID-19 [Internet]. Lancet. 2020; p. 1417&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7172722</ArticleId><ArticleId IdType="pubmed">32325026</ArticleId></ArticleIdList></Reference><Reference><Citation>Rotoli BM, Barilli A, Visigalli R, Ferrari F, Dall&#x2019;Asta V. Endothelial cell activation by SARS-CoV-2 spike S1 protein: a crosstalk between endothelium and innate immune cells. Biomedicines. 2021;9:1220.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8470710</ArticleId><ArticleId IdType="pubmed">34572407</ArticleId></ArticleIdList></Reference><Reference><Citation>Fogarty H, Townsend L, Morrin H, Ahmad A, Comerford C, Karampini E, et al. Persistent endotheliopathy in the pathogenesis of long COVID syndrome. J Thromb Haemost. 2021;19:2546&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8420256</ArticleId><ArticleId IdType="pubmed">34375505</ArticleId></ArticleIdList></Reference><Reference><Citation>Klok FA, Kruip MJHA, van der Meer NJM, Arbous MS, Gommers DAMPJ, Kant KM, et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. 2020;191:145&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7146714</ArticleId><ArticleId IdType="pubmed">32291094</ArticleId></ArticleIdList></Reference><Reference><Citation>Rezabakhsh A, Sadat-Ebrahimi S-R, Ala A, Nabavi SM, Banach M, Ghaffari S. A close-up view of dynamic biomarkers in the setting of COVID-19: Striking focus on cardiovascular system. J Cell Mol Med. 2022;26:274&#x2013;86.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8743667</ArticleId><ArticleId IdType="pubmed">34894069</ArticleId></ArticleIdList></Reference><Reference><Citation>Sibila O, Perea L, Albacar N, Mois&#xe9;s J, Cruz T, Mendoza N, et al. Elevated plasma levels of epithelial and endothelial cell markers in COVID-19 survivors with reduced lung diffusing capacity six months after hospital discharge. Respir Res. 2022;23:1&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8860292</ArticleId><ArticleId IdType="pubmed">35189887</ArticleId></ArticleIdList></Reference><Reference><Citation>Chioh FWJ, Fong SW, Young BE, Wu KX, Siau A, Krishnan S, et al. Convalescent covid-19 patients are susceptible to endothelial dysfunction due to persistent immune activation. Elife. 2021;10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7987341</ArticleId><ArticleId IdType="pubmed">33752798</ArticleId></ArticleIdList></Reference><Reference><Citation>Mancuso P, Gidaro A, Gregato G, Raveane A, Cremonesi P, Quarna J, et al. Circulating endothelial progenitors are increased in COVID-19 patients and correlate with SARS-CoV-2 RNA in severe cases. J Thromb Haemost. 2020;18:2744&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7436444</ArticleId><ArticleId IdType="pubmed">32762140</ArticleId></ArticleIdList></Reference><Reference><Citation>Poyatos P, Luque N, Eizaguirre S, Sabater G, Sebasti&#xe1;n L, Francisco-Albesa &#xcd;, et al. Post-COVID-19 patients show an increased endothelial progenitor cell production. Transl Res. 2022;243:14&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8785258</ArticleId><ArticleId IdType="pubmed">35085821</ArticleId></ArticleIdList></Reference><Reference><Citation>Tousoulis D, Andreou I, Antoniades C, Tentolouris C, Stefanadis C. Role of inflammation and oxidative stress in endothelial progenitor cell function and mobilization: therapeutic implications for cardiovascular diseases. Atherosclerosis. 2008;201:236&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pubmed">18599065</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoder MC, Mead LE, Prater D, Krier TR, Mroueh KN, Li F, et al. Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood. 2007; p. 1801&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1801067</ArticleId><ArticleId IdType="pubmed">17053059</ArticleId></ArticleIdList></Reference><Reference><Citation>Huertas A, Montani D, Savale L, Pichon J, Tu L, Parent F, et al. Endothelial cell dysfunction: a major player in SARS-CoV-2 infection (COVID-19)?. Eur Respir J NLM (Medline). 2020; p. 1524&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7301835</ArticleId><ArticleId IdType="pubmed">32554538</ArticleId></ArticleIdList></Reference><Reference><Citation>Sen S, McDonald SP, Coates PTH, Bonder CS. Endothelial progenitor cells: novel biomarker and promising cell therapy for cardiovascular disease. Clin Sci. 2011; p. 263&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pubmed">21143202</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis. 2022;22:e102&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Puntmann VO, Carerj ML, Wieters I, Fahim M, Arendt C, Hoffmann J, et al. Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020;5:1265&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7385689</ArticleId><ArticleId IdType="pubmed">32730619</ArticleId></ArticleIdList></Reference><Reference><Citation>Stanojevic S, Kaminsky DA, Miller MR, Thompson B, Aliverti A, Barjaktarevic I, et al. ERS/ATS technical standard on interpretive strategies for routine lung function tests. Eur Respir J. 2022;60:2101499.</Citation><ArticleIdList><ArticleId IdType="pubmed">34949706</ArticleId></ArticleIdList></Reference><Reference><Citation>Gallogly S, Fujisawa T, Hung JD, Brittan M, Skinner EM, Mitchell AJ, et al. Generation of a novel in vitro model to study endothelial dysfunction from atherothrombotic specimens. Cardiovasc Drugs Ther. 2021;2021:1&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8578063</ArticleId><ArticleId IdType="pubmed">33608862</ArticleId></ArticleIdList></Reference><Reference><Citation>Tura O, Skinner EM, Barclay R, Samuel K, Gallagher RCJ, Brittan M, et al. Late outgrowth endothelial cells resemble mature endothelial cells and are not derived from bone marrow. Stem Cells. 2013;31:338&#x2013;48.</Citation><ArticleIdList><ArticleId IdType="pubmed">23165527</ArticleId></ArticleIdList></Reference><Reference><Citation>Alvarado-Moreno JA, Davila-Moreno J, Dominguez-Reyes V, Arreola-Diaz R, Isordia-Salas I, Chavez-Gonzalez A, et al. Morphological and functional alterations in endothelial colony-forming cells from recovered COVID-19 patients. Thromb Res. 2021;206:55&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8363179</ArticleId><ArticleId IdType="pubmed">34411875</ArticleId></ArticleIdList></Reference><Reference><Citation>Modarai B, Burnand KG, Sawyer B, Smith A. Endothelial progenitor cells are recruited into resolving venous thrombi. Circulation. 2005;111:2645&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pubmed">15883207</ArticleId></ArticleIdList></Reference><Reference><Citation>Lala A, Johnson KW, Januzzi JL, Russak AJ, Paranjpe I, Richter F, et al. Prevalence and impact of myocardial injury in patients hospitalized with COVID-19 INfection. J Am Coll Cardiol. 2020;76:533&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7279721</ArticleId><ArticleId IdType="pubmed">32517963</ArticleId></ArticleIdList></Reference><Reference><Citation>Lippi G, Lavie CJ, Sanchis-Gomar F. Cardiac troponin I in patients with coronavirus disease 2019 (COVID-19): Evidence from a meta-analysis. Prog Cardiovasc Dis. 2020;63:390&#x2013;1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7127395</ArticleId><ArticleId IdType="pubmed">32169400</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L, Zhao P, Tang D, Zhu T, Han R, Zhan C, et al. Cardiac involvement in patients recovered from COVID-2019 identified using magnetic resonance imaging. JACC Cardiovasc Imaging. 2020;13:2330&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7214335</ArticleId><ArticleId IdType="pubmed">32763118</ArticleId></ArticleIdList></Reference><Reference><Citation>S&#xf8;yseth V, Kononova N, Neukamm A, Holmedahl NH, Hagve TA, Omland T, et al. Systemic inflammation induced by exacerbation of COPD or pneumonia in patients with COPD induces cardiac troponin elevation. BMJ Open Respir Res. 2021;8:1&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8404456</ArticleId><ArticleId IdType="pubmed">34452935</ArticleId></ArticleIdList></Reference><Reference><Citation>Mir&#xf3; &#xd2;, Jim&#xe9;nez S, Mebazaa A, Freund Y, Burillo-Putze G, Mart&#xed;n A, et al. Pulmonary embolism in patients with COVID-19: incidence, risk factors, clinical characteristics, and outcome. Eur Heart J. 2021;42:3127&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8344714</ArticleId><ArticleId IdType="pubmed">34164664</ArticleId></ArticleIdList></Reference><Reference><Citation>Fish-Trotter H, Ferguson JF, Patel N, Arora P, Allen NB, Bachmann KN, et al. Inflammation and circulating natriuretic peptide levels. Circ Hear Fail. 2020;13:135&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7375923</ArticleId><ArticleId IdType="pubmed">32507024</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L, Chen F, Bai L, Bai L, Huang Z, Peng Y. Association between NT-proBNP level and the severity of COVID-19 pneumonia. Cardiol Res Pract. 2021;2021:5537275.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8266470</ArticleId><ArticleId IdType="pubmed">34306746</ArticleId></ArticleIdList></Reference><Reference><Citation>Gul M, Ozyilmaz S, Bastug Gul Z, Kacmaz C, Satilmisoglu MH. Evaluation of cardiac injury with biomarkers and echocardiography after COVID-19 infection. J Physiol Pharmacol. 2022;73.</Citation><ArticleIdList><ArticleId IdType="pubmed">35639041</ArticleId></ArticleIdList></Reference><Reference><Citation>Feld J, Tremblay D, Thibaud S, Kessler A, Naymagon L. Ferritin levels in patients with COVID-19: A poor predictor of mortality and hemophagocytic lymphohistiocytosis. Int J Lab Hematol. 2020;42:773&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7436675</ArticleId><ArticleId IdType="pubmed">32790918</ArticleId></ArticleIdList></Reference><Reference><Citation>Abohelwa M, Peterson CJ, Landis D, Le D, Conde C, DeWare C, et al. Clinical characteristics of hospital follow-up for patients hospitalized from SARS CoV-2 (COVID 19) in an academic outpatient internal medicine clinic. J Prim Care Community Health. 2022;13:1&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9619072</ArticleId><ArticleId IdType="pubmed">36314373</ArticleId></ArticleIdList></Reference><Reference><Citation>Banchini F, Cattaneo GM, Capelli P. Serum ferritin levels in inflammation: a retrospective comparative analysis between COVID-19 and emergency surgical non-COVID-19 patients. World J Emerg Surg. 2021;16:9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7938265</ArticleId><ArticleId IdType="pubmed">33685484</ArticleId></ArticleIdList></Reference><Reference><Citation>Taneri PE, G&#xf3;mez-Ochoa SA, Llanaj E, Raguindin PF, Rojas LZ, Roa-D&#xed;az ZM, et al. Anemia and iron metabolism in COVID-19: a systematic review and meta-analysis. Eur J Epidemiol. 2020;35:763&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7438401</ArticleId><ArticleId IdType="pubmed">32816244</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahroum N, Alghory A, Kiyak Z, Alwani A, Seida R, Alrais M, et al. Ferritin &#x2013; from iron, through inflammation and autoimmunity, to COVID-19. J Autoimmun. 2022;126: 102778.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8647584</ArticleId><ArticleId IdType="pubmed">34883281</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuragano T, Joki N, Hase H, Kitamura K, Murata T, Fujimoto S, et al. Low transferrin saturation (TSAT) and high ferritin levels are significant predictors for cerebrovascular and cardiovascular disease and death in maintenance hemodialysis patients. PLoS ONE. 2020;15:1&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7467218</ArticleId><ArticleId IdType="pubmed">32877424</ArticleId></ArticleIdList></Reference><Reference><Citation>Balla J, Vercellotti GM, Jeney V, Yachie A, Varga Z, Jacob HS, et al. Heme, heme oxygenase, and ferritin: how the vascular endothelium survives (and Dies) in an iron-rich environment. Antioxid Redox Signal. 2007;9:2119&#x2013;37.</Citation><ArticleIdList><ArticleId IdType="pubmed">17767398</ArticleId></ArticleIdList></Reference><Reference><Citation>Araujo JA, Zhang M, Yin F. Heme oxygenase-1, oxidation, inflammation, and atherosclerosis. Front Pharmacol. 2012;3:119.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3400084</ArticleId><ArticleId IdType="pubmed">22833723</ArticleId></ArticleIdList></Reference><Reference><Citation>Meizlish ML, Pine AB, Goshua G, Chang C-H, Zhang H, Bishai J, et al. Circulating markers of angiogenesis and endotheliopathy in COVID-19. Pulm Circ. 2020;10:2045894020966547.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7691906</ArticleId><ArticleId IdType="pubmed">33282193</ArticleId></ArticleIdList></Reference><Reference><Citation>Beltr&#xe1;n-Camacho L, Eslava-Alc&#xf3;n S, Rojas-Torres M, S&#xe1;nchez-Morillo D, Martinez-Nicol&#xe1;s MaP, Mart&#xed;n-Bermejo V, et al. The serum of COVID-19 asymptomatic patients up-regulates proteins related to endothelial dysfunction and viral response in circulating angiogenic cells ex-vivo. Mol Med. 2022;28:1&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8994070</ArticleId><ArticleId IdType="pubmed">35397534</ArticleId></ArticleIdList></Reference><Reference><Citation>Willems LH, Jacobs LMC, Groh LA, ten Cate H, Spronk HMH, Wilson-Storey B, et al. Vascular Function, Systemic Inflammation, and Coagulation Activation 18 Months after COVID-19 Infection: An Observational Cohort Study. J Clin Med. 2023;12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9965558</ArticleId><ArticleId IdType="pubmed">36835948</ArticleId></ArticleIdList></Reference><Reference><Citation>Ungvari Z, Tarantini S, Kiss T, Wren JD, Giles CB, Griffin CT, et al. Endothelial dysfunction and angiogenesis impairment in the ageing vasculature. Nat Rev Cardiol. 2018;15:555&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6612360</ArticleId><ArticleId IdType="pubmed">29795441</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu R, Liu TW, Liu F. Exogenous urokinase inhibits proteasomal degradation of its cognate urokinase plasminogen activator receptor. Front Pharmacol. 2022;13: 754271.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9411529</ArticleId><ArticleId IdType="pubmed">36034808</ArticleId></ArticleIdList></Reference><Reference><Citation>Lang IM, Moser KM, Schleef RR. Elevated expression of urokinase-like plasminogen activator and plasminogen activator inhibitor type 1 during the vascular remodeling associated with pulmonary thromboembolism. Arterioscler Thromb Vasc Biol. 1998;18:808&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pubmed">9598841</ArticleId></ArticleIdList></Reference><Reference><Citation>Alias S, Lang IM. Coagulation and the vessel wall in pulmonary embolism. Pulm Circ. 2013;3:728&#x2013;38.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4070824</ArticleId><ArticleId IdType="pubmed">25006391</ArticleId></ArticleIdList></Reference><Reference><Citation>Bontekoe E, Brailovsky Y, Hoppensteadt D, Bontekoe J, Siddiqui F, Newman J, et al. Upregulation of inflammatory cytokines in pulmonary embolism using biochip-array profiling. Clin Appl Thromb. 2021;27:1&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8113361</ArticleId><ArticleId IdType="pubmed">33969714</ArticleId></ArticleIdList></Reference><Reference><Citation>Smadja DM, Laurendeau I, Avignon C, Vidaud M, Aiach M, Gaussem P. The angiopoietin pathway is modulated by PAR-1 activation on human endothelial progenitor cells. J Thromb Haemost. 2006;4:2051&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">16803467</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S, Wegman-Ostrosky T, Perelman C, Sepulveda R, Rebolledo PA, Cuapio A, et al. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci Rep. 2021;11:16144.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Sykes DL, Holdsworth L, Jawad N, Gunasekera P, Morice AH, Crooks MG. Post-COVID-19 Symptom Burden: What is Long-COVID and How Should We Manage It? Lung. 2021;199:113&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7875681</ArticleId><ArticleId IdType="pubmed">33569660</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397:220&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>